ACTRN12609000848202
Completed
Not Applicable
A clinical study in healthy volunteers to determine whether orally consumed tocopheryl phosphates are incorporated into secreted sebum
Phosphagenics Limited0 sites40 target enrollmentSeptember 30, 2009
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Phosphagenics Limited
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Provision of written informed consent.
- •\- Healthy male or female.
- •\- At least 18 years old.
- •\- Fitzpatrick skin types II or III.
Exclusion Criteria
- •\- Pregnant or breastfeeding.
- •\- History of dermatological disorders.
- •\- Current medical problems or systemic medication.
- •\- Oral or topical anti\-oxidant supplementation within 14 days of baseline.
- •\- Smokers.
- •\- Exposure to intense solar or artificial UV/ tanning salons in the 3 months prior to baseline.
- •\- Unable or unwilling to use Vitamin E free skin care products for the duration of the trial.
- •\- Taking warfarin or blood thinning medications.
- •\- Dependent on iron supplements.
- •\- Diabetes, hyperthyroidism, or heart disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren(registered trademark) gelMuscular or joint pain relief in healthy volunteers currently experiencing no painOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12609000505202Phosphagenics Limited24
Active, not recruiting
Phase 1
Bioavailability study with LCZ696Study in healthy subjectsTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2017-001803-57-Outside-EU/EEAovartis Pharmaceuticals Corp40
Withdrawn
Not Applicable
A study in healthy volunteers to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of BN201, an investigational compound for the treatment of acute optic neuritis.inflammation of the optic nerve.10030061NL-OMON42731Bionure Pharma S.L. Barcelona32
Recruiting
Not Applicable
Clinical study with healthy volunteer to measure the volume of gastric fluid after oral drug administratiodigestive disorderJPRN-UMIN000002860Faculty of Pharmaceutical Sciences, Setsunan University8
Completed
Phase 1
A study in healthy volunteers to look at how different formulations (recipes) of the test medicine firibastat (QGC001) are taken up and broken down by the bodyISRCTN24120533Quantum Genomics (France)30